US Stock MarketDetailed Quotes

NGENF NERVGEN PHARMA CORP

Watchlist
  • 1.432
  • -0.049-3.28%
15min DelayClose Apr 17 16:00 ET
100.10MMarket Cap-5964P/E (TTM)

NERVGEN PHARMA CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-30.62%3.42M
-24.45%4.77M
-5.75%4.72M
79.73%23.03M
63.60%6.78M
34.27%4.92M
128.12%6.31M
124.39%5M
14.43%12.81M
-6.05%4.15M
Selling and administrative expenses
48.98%2.55M
108.99%3.23M
19.20%1.67M
6.75%6.34M
4.10%1.68M
3.84%1.71M
-9.65%1.54M
-5.52%1.4M
18.02%5.94M
42.72%1.61M
-General and administrative expense
48.98%2.55M
108.99%3.23M
19.20%1.67M
6.75%6.34M
4.10%1.68M
3.84%1.71M
-9.65%1.54M
-5.52%1.4M
18.02%5.94M
42.72%1.61M
Research and development costs
-73.71%837.57K
-68.00%1.52M
-16.11%3.02M
141.77%16.61M
100.60%5.08M
58.00%3.19M
352.75%4.75M
382.45%3.6M
11.49%6.87M
-22.86%2.53M
Depreciation amortization depletion
2.89%25.02K
3.26%24.56K
2,467.79%24.32K
3,471.81%73.37K
3,057.92%24.32K
5,581.31%24.32K
125.03%23.79K
121.26%947
44.14%2.05K
80.33%770
-Depreciation and amortization
2.89%25.02K
3.26%24.56K
2,467.79%24.32K
3,471.81%73.37K
3,057.92%24.32K
5,581.31%24.32K
125.03%23.79K
121.26%947
44.14%2.05K
80.33%770
Operating profit
30.62%-3.42M
24.45%-4.77M
5.75%-4.72M
-79.73%-23.03M
-63.60%-6.78M
-34.27%-4.92M
-128.12%-6.31M
-124.39%-5M
-14.43%-12.81M
6.05%-4.15M
Net non-operating interest income expense
130.34%136.55K
316.28%139.59K
773.19%151.39K
-1,164.70%-313.2K
569.88%86.01K
-6,954.81%-450.09K
528.80%33.53K
270.61%17.34K
56.04%29.42K
162.25%12.84K
Non-operating interest income
111.67%136.55K
316.28%139.59K
773.19%151.39K
584.62%201.4K
569.88%86.01K
882.52%64.51K
528.80%33.53K
270.61%17.34K
56.04%29.42K
162.25%12.84K
Non-operating interest expense
--0
----
----
--514.6K
--0
--514.6K
----
----
--0
--0
Other net income (expense)
-154.49%-1.02M
-238.73%-132.12K
-840.57%-143.77K
4,636.56%2.62M
5,889.78%757.77K
2,971.58%1.88M
-234.03%-39.01K
188.57%19.41K
706.31%55.23K
91.96%-13.09K
Gain on sale of security
-154.49%-1.02M
-238.73%-132.12K
-840.57%-143.77K
4,636.56%2.62M
5,889.78%757.77K
2,971.58%1.88M
-234.03%-39.01K
188.57%19.41K
706.31%55.23K
91.96%-13.09K
Income before tax
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
-121.04%-4.97M
-13.77%-12.73M
9.29%-4.15M
Income tax
Net income
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
-121.04%-4.97M
-13.77%-12.73M
9.29%-4.15M
Net income continuous Operations
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
-121.04%-4.97M
-13.77%-12.73M
9.29%-4.15M
Minority interest income
Net income attributable to the parent company
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
-121.04%-4.97M
-13.77%-12.73M
9.29%-4.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
-121.04%-4.97M
-13.77%-12.73M
9.29%-4.15M
Basic earnings per share
-16.67%-0.07
38.46%-0.08
27.27%-0.08
-21.88%-0.39
-11.11%-0.1
33.33%-0.06
-85.71%-0.13
-83.33%-0.11
8.57%-0.32
35.71%-0.09
Diluted earnings per share
-16.67%-0.07
38.46%-0.08
27.27%-0.08
-21.88%-0.39
-11.11%-0.1
33.33%-0.06
-85.71%-0.13
-83.33%-0.11
8.57%-0.32
35.71%-0.09
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -30.62%3.42M-24.45%4.77M-5.75%4.72M79.73%23.03M63.60%6.78M34.27%4.92M128.12%6.31M124.39%5M14.43%12.81M-6.05%4.15M
Selling and administrative expenses 48.98%2.55M108.99%3.23M19.20%1.67M6.75%6.34M4.10%1.68M3.84%1.71M-9.65%1.54M-5.52%1.4M18.02%5.94M42.72%1.61M
-General and administrative expense 48.98%2.55M108.99%3.23M19.20%1.67M6.75%6.34M4.10%1.68M3.84%1.71M-9.65%1.54M-5.52%1.4M18.02%5.94M42.72%1.61M
Research and development costs -73.71%837.57K-68.00%1.52M-16.11%3.02M141.77%16.61M100.60%5.08M58.00%3.19M352.75%4.75M382.45%3.6M11.49%6.87M-22.86%2.53M
Depreciation amortization depletion 2.89%25.02K3.26%24.56K2,467.79%24.32K3,471.81%73.37K3,057.92%24.32K5,581.31%24.32K125.03%23.79K121.26%94744.14%2.05K80.33%770
-Depreciation and amortization 2.89%25.02K3.26%24.56K2,467.79%24.32K3,471.81%73.37K3,057.92%24.32K5,581.31%24.32K125.03%23.79K121.26%94744.14%2.05K80.33%770
Operating profit 30.62%-3.42M24.45%-4.77M5.75%-4.72M-79.73%-23.03M-63.60%-6.78M-34.27%-4.92M-128.12%-6.31M-124.39%-5M-14.43%-12.81M6.05%-4.15M
Net non-operating interest income expense 130.34%136.55K316.28%139.59K773.19%151.39K-1,164.70%-313.2K569.88%86.01K-6,954.81%-450.09K528.80%33.53K270.61%17.34K56.04%29.42K162.25%12.84K
Non-operating interest income 111.67%136.55K316.28%139.59K773.19%151.39K584.62%201.4K569.88%86.01K882.52%64.51K528.80%33.53K270.61%17.34K56.04%29.42K162.25%12.84K
Non-operating interest expense --0----------514.6K--0--514.6K----------0--0
Other net income (expense) -154.49%-1.02M-238.73%-132.12K-840.57%-143.77K4,636.56%2.62M5,889.78%757.77K2,971.58%1.88M-234.03%-39.01K188.57%19.41K706.31%55.23K91.96%-13.09K
Gain on sale of security -154.49%-1.02M-238.73%-132.12K-840.57%-143.77K4,636.56%2.62M5,889.78%757.77K2,971.58%1.88M-234.03%-39.01K188.57%19.41K706.31%55.23K91.96%-13.09K
Income before tax -23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M-121.04%-4.97M-13.77%-12.73M9.29%-4.15M
Income tax
Net income -23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M-121.04%-4.97M-13.77%-12.73M9.29%-4.15M
Net income continuous Operations -23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M-121.04%-4.97M-13.77%-12.73M9.29%-4.15M
Minority interest income
Net income attributable to the parent company -23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M-121.04%-4.97M-13.77%-12.73M9.29%-4.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M-121.04%-4.97M-13.77%-12.73M9.29%-4.15M
Basic earnings per share -16.67%-0.0738.46%-0.0827.27%-0.08-21.88%-0.39-11.11%-0.133.33%-0.06-85.71%-0.13-83.33%-0.118.57%-0.3235.71%-0.09
Diluted earnings per share -16.67%-0.0738.46%-0.0827.27%-0.08-21.88%-0.39-11.11%-0.133.33%-0.06-85.71%-0.13-83.33%-0.118.57%-0.3235.71%-0.09
Dividend per share
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg